Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-35.33	-14.24	36.66	42.48	-6.2
Depreciation & Amortization	1.28	1.31	0.34	0.14	0.07
Share-Based Compensation	8.34	7.54	5.51	2.74	1.09
Other Operating Activities	3.64	11.95	-1.42	-17.19	-0.48
Operating Cash Flow	-22.08	6.57	41.08	28.17	-5.53
Operating Cash Flow Growth	-	-84.01%	45.86%	-	-
Capital Expenditures	-1.37	-1.43	-0.67	-0.77	-0.11
Acquisitions	0	0	1.69	-0.71	-0.32
Change in Investments	16.75	-56.74	3.08	-4.34	0
Investing Cash Flow	15.39	-58.17	4.1	-5.82	-0.44
Share Issuance / Repurchase	-1.36	-14.03	0.45	21.2	5.5
Other Financing Activities	-	-	-	-1.46	0.41
Financing Cash Flow	-1.36	-14.03	0.45	19.74	5.9
Net Cash Flow	-8.06	-65.63	45.63	42.08	-0.06
Free Cash Flow	-23.45	5.14	40.41	27.39	-5.64
Free Cash Flow Growth	-	-87.28%	47.54%	-	-
Free Cash Flow Margin	-344.20%	15.02%	41.28%	36.74%	-2622.80%
Free Cash Flow Per Share	-0.80	0.16	1.40	1.02	-0.34

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).